A4C-33180-60310
2 vaccinations
9 coded responses
25 check-ins
9 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 809 / CO
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
- 2020-12-18
-
2020-12-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2020-12-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Muscle or body aches, NauseaAdult check-in
-
2020-12-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2020-12-22
Survey response — days 1–6 daily, dose 1MedDRA: Condition aggravated, Hypersensitivity, Pre-existing disease — Feeling: Fair · Joint pains, Muscle or body achesFree text: Chronic musculoskeletal and allergy issues seems to be continually worse and constant since injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-23
Survey response — days 1–6 daily, dose 1MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good · Joint pains, Muscle or body achesFree text: Chronic musculoskeletal and allergy issues continue to be worse than baselineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-24
Survey response — days 1–6 daily, dose 1MedDRA: Condition aggravated, Dermatitis, Hypersensitivity — Feeling: Good · Joint pains, Muscle or body achesFree text: Continued exaxerbation of musculoskeletal issues and allergies, now dermatitis to elbow on right armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-25
Survey response — day 7, dose 1MedDRA: Condition aggravated, Dermatitis — Feeling: Good · Joint pains, Muscle or body achesFree text: Continued exaxerbation or muculoskeletal and allergic issues, though dermatitis slightly better, closer to baselineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-01
-
2021-01-08
Dose 2 — Pfizer-BioNTech
-
2021-01-08
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-10
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-11
Survey response — days 1–6 daily, dose 2MedDRA: Eye swelling, Injection site erythema, Injection site swelling, Lymphadenopathy — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesFree text: Eye and lymph node swelling improved, injection site more red but maybe less swollenMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-11
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-12
Survey response — days 1–6 daily, dose 2MedDRA: Eye swelling, Lymphadenopathy — Feeling: Good · Site: Pain, Redness, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tirednessFree text: Eye and lymph swelling still present, unchanged from yesterdayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-14
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy, Mass — Feeling: Good · Site: Pain, Redness, Swelling · Headache, Muscle or body achesFree text: Lump in arm down to dime size now. Lymph nodes actually more swollen again yesterday and today.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-15
Survey response — day 7, dose 2MedDRA: Injection site swelling, Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Lymph nodes and injection site still swollenMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-22
Survey response — day 14, dose 2MedDRA: Hypersensitivity, Lymphadenopathy, Pain, Pre-existing disease, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Lymph node swelling gets a little better, then a little worse again. Baseline pain and allergy symptoms are syill worse compared with baseline/ pre vaccines. Have appointment with PCP next week to discuss these issues. · Healthcare visit (other): Pending in person PCP visitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-22
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-03-31
-
2021-04-01
Call successfulParticipant prefers to complete VAERS report online
- 2021-04-09
- 2021-07-09
- 2022-01-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech |
Call center
4 call center cases
4 successful
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Chronic musculoskeletal and allergy issues seems to be continually worse and constant since injection
Systemic reaction (other): Chronic musculoskeletal and allergy issues continue to be worse than baseline
Systemic reaction (other): Continued exaxerbation of musculoskeletal issues and allergies, now dermatitis to elbow on right arm
Release 1 — day 7, dose 1
Systemic reaction (other): Continued exaxerbation or muculoskeletal and allergic issues, though dermatitis slightly better, closer to baseline
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Eye and lymph node swelling improved, injection site more red but maybe less swollen
Systemic reaction (other): Eye and lymph swelling still present, unchanged from yesterday
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Lump in arm down to dime size now. Lymph nodes actually more swollen again yesterday and today.
Release 2 — day 7, dose 2
Systemic reaction (other): Lymph nodes and injection site still swollen
Release 2 — day 14, dose 2
Symptoms: Lymph node swelling gets a little better, then a little worse again. Baseline pain and allergy symptoms are syill worse compared with baseline/ pre vaccines. Have appointment with PCP next week to discuss these issues.
Healthcare visit (other): Pending in person PCP visit
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Condition aggravated | ✓ | ✓ | ✓ |
| SRO | Dermatitis | ✓ | ✓ | ✓ |
| SRO | Eye swelling | ✓ | ✓ | ✓ |
| SRO | Hypersensitivity | ✓ | ✓ | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site swelling | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Mass | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release